Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them

“We wondered, was that only a U.S. phenomenon?” Novo Nordisk CEO Lars Fruergaard Jørgensen said of the demand for weight-loss drugs in Europe. Read More